Join Dr. John Leonard for a Twitter Chat on Sunday, October 4 at 1pm
Category: Patient Education
Dr. Richard Furman Discusses the Approval of Ibrutinib for the Treatment of Patients with Waldenstrom’s Macroglobulinemia
In this Onc Live video, Dr. Richard Furman, Director of the CLL Research Center discusses the findings of a recent study that led to the approval of ibrutinib as a mono-therapy for patients with Waldenstrom’s Macroglobulinemia.
A full listing of open clinical trials for Waldenstrom’s Macroglobulinemia can be found here.
Dr. John Leonard to Speak at ASH Meeting on Hematological Malignancies
This weekend at the ASH Meeting on Hematological Malignancies (ASHMHM15), Lymphoma Program Director, Dr. John Leonard will discuss how he treats patients with mantle cell lymphoma, and specifically on how to overcome mantle cell lymphoma resistance to ibrutinib.
New Developments in Lymphoma 